As of 1:27pm ET
| -0.0165 / -0.98%|
The 3 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 3.60, with a high estimate of 4.00 and a low estimate of 3.20. The median estimate represents a +115.12% increase from the last price of 1.67.
The current consensus among 3 polled investment analysts is to Hold stock in Anthera Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.